AndhraNews.net
Home » Business News » 2013 » May » May 8, 2013

Implant Sciences Sponsors Global Sports Management Summit


May 8, 2013 - Wilmington, MA

Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it is a supporting sponsor of the Global Sports Management Summit, which will take place on May 8 to 10 in Chicago. The Global Sports Management Summit is the premier invitation-only meeting created for senior executives from the NFL, NBA, MLB, NHL, MLS, NCAA, European Football and other professional sports globally. As a sponsor, Implant Sciences' executives will have the opportunity to engage with the key decision makers managing sporting events, venues and associated security matters.

Implant Sciences' Quantum Sniffers have been used to provide security at some of the highest profile sporting events in the world including the 2008 Beijing Olympics, the 2011 Summer Universiade Games in Shenzhen, China, and the 2012 Special Olympics in London.

"While intelligence can often uncover potential attacks and law enforcement can interdict before an attack strikes, no one method can be completely effective at a sporting venue, or any other location. Good security involves multiple layers and techniques," stated Implant Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones. "At sporting events, there is one item that offers a unique security screening opportunity: the event ticket."

Quantum Sniffers are explosives trace detection systems that detect and identify threats from small amounts of explosives left behind after a person handles explosives. These traces stick to the hands and are subsequently transferred to everything an individual touches. Detectable amounts of explosives can be left on event tickets, making them a good vehicle for evaluating if someone has handled explosives.

"We are in talks with sporting events managers and are proposing a fast, non-contact method of security using our Quantum Sniffers. Our systems can scan tickets at the same time that fans present these tickets as they enter a stadium or arena, without creating a bottleneck or delay. This approach provides a combination of excellent detection performance with a strong deterrence factor," added Jones. "We believe the QS-H150 is the only ETD system in the market capable of achieving this feat, due to our continuous non-contact sampling capability."

"Our systems offer a non-intrusive and cost-effective way to add an extra layer of security at sporting events so that fans can enjoy a game with greater peace of mind. Having served to protect global events, including the Olympics, we realize Quantum Sniffers can be deployed on the home front here in the U.S. as well as abroad," stated Implant Sciences' President and CEO, Glenn D. Bolduc.

About the Quantum Sniffer™ QS-H150 Handheld Explosives Trace Detector

The Quantum Sniffer QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.

About Implant Sciences

Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. Implant Sciences has developed proprietary technologies used in its commercial explosives and drugs trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA approval for air cargo screening, the Company's QS-B220 has also received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; the risks that our markets are subject to technological change and that our success depends on our ability to develop and introduce new products; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Implant Sciences Corporation
Company Contact:
Glenn Bolduc
CEO
978-752-1700
Email Contact

or

Investor Contact:
Laurel Moody
646-810-0608
Email Contact

MarketWire

Comment on this story

Share